Droperidol Injection
Last Updated: June 11, 2015
Status: Current
Products Affected - Description
Droperidol injection, 2.5 mg/mL, American Regent
2 mL vials (NDC 00517-9702-25)
2 mL vials (NDC 00517-9702-25)
Droperidol injection, 2.5 mg/mL, Hospira
2 mL ampule (NDC 00409-1187-01)
2 mL ampule (NDC 00409-1187-01)
Reason for the Shortage
- American Regent has droperidol injection on unavailable due to manufacturing delays.
- Hospira has droperidol unavailable due to shortage of raw material.
Available Products
No presentations are available.
Estimated Resupply Dates
- American Regent cannot estimate when droperidol injection will return to the market. Product has not been available since 2013.
- Hospira cannot estimate when droperidol injection will return to the market. Product has not been available since late-2011.
Related Shortages
- Amobarbital Injection — Resolved
- Chloral Hydrate Oral Solution and Capsules — No Longer Available
- Dexmedetomidine Injection — Resolved
- Hydroxyzine Hydrochloride Injection — Resolved — No Commercially Available Preparations
- Lorazepam injectable presentations — Current
- Midazolam Injections — Resolved
- Zolpidem Tartrate Immediate Release Tablets — Current
Updated
June 11, March 23, January 14, 2015; October 16, August 6, May 1, February 10, 2014; November 15, September 18, July 18, May 17, March 15 and 25, February 13, January 9, 2013; December 10, October 5 and 24, August 28, July 6, May 17, April 13, March 5, January 3, 2012; November 30, October 20, September 9 and 30, August 15, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
